TrialCancer science2026
Pembrolizumab for Early-Stage Triple-Negative Breast Cancer: KEYNOTE-522 Japan Subgroup Analysis.
Masato Takahashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
TrialCancer science2026
Masato Takahashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.